This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration
logo_not_found
Event
Hybrid Event

Accelerate Ideas, Partnerships and Opportunities

Book your SLOT NOW
  • Start 9:00am - 6:00pm
  • San Francisco, CA, USA
    Registration Venue
     

    About Conference

    Sciinov Group is ecstatic to invite you to its “4th edition of Global Longevity Federation” (GLF 2025) which is going to take place during March 10-11, 2025 as a Hybrid Event having both online and in-person versions at San Francisco, CA, USA.

    GLF 2025 is an annual meeting where Longevity Clinics and Physicians, Pharmacists, Businesses and Investors come together to meet the latest innovations for applications in clinical practice. GLF 2024 brings together the world’s most prominent clinics to spearhead the cutting-edge ...

    Readmore

    Author's Login
    Abstract Tracking Tool

    Scientific Sessions

    Archived Speaker

    Our Conference

    Past Edition Speakers

    Will be bringing you the latest scientific research, clinical best practice and an opportunity to network

    View All Speakers
    2

    Peter Fedichev

    Yedong Huang

    Jason C. Mercurio

    Georgios Mitrou
    1

    Aubrey de Grey

    Ryan A. McNally

    Lucija Sironic

    Louis Dischler

    Thomas Weldon

    Michael Suswal

    A. Christopher Wikman

    Lucia Hue Fontaine

    Alina Rui Su

    ask & questions

    answer

    We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables. 

    If you are interested in being considered as a speaker, submit your proposal/abstract Online

     

     

     

    answer

    Once your abstract got accepted, the Presenting Author of an accepted oral or poster abstract must register for the Annual Meeting (fees apply)

    answer

    Visas for non-GCC nationals may take several weeks to process, so avoid delay by ensuring your booking is confirmed by registering today. We accept no responsibility for denials or delays in the processing of visas.

    answer

    In an effort to allow for appropriate social distancing, we are taking a number of measures to reduce density.

    Please be assured that the health and safety of our attendees is paramount to us. Given the latest conditions, only those fully vaccinated against COVID-19 are permitted to attend. You will be required to provide proof of vaccination at registration. Additionally, please be advised that per local guidelines in Rome, Italy, at this time masks are required in indoor public places regardless of vaccination status.


    view all Faq's

    Recent Updates

    09 OCT
    2024

    Arda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion Therapies

    Arda Therapeutics, a pioneer in targeted cell depletion therapies for chronic diseases, today announced the successful completion of a $43 million Series A financing round. The round was led by existing investor Andreessen Horowitz (a16z Bio + Health), with participation from Two Sigma Ventures, RV Invest, Eli Lilly and Company, GV, Biovision Ventures, Valhalla Ventures, Indicator Ventures, Alumni Ventures, LifeLink Ventures, Mana Ventures, Gaingels and ExitFund.Readmore

    03 OCT
    2024

    Promising ‘first’ in Alzheimer’s drug development

    For the first time, scientists have developed a drug that works on both major aggregation-promoting ‘hotspots’ of the Tau protein - addressing a critical gap in current treatments.Readmore

    15 OCT
    2024

    Shift Bioscience raises $16M to advance cell simulation AI platform

    Shift Bioscience raises $16M to advance cell simulation AI platform. Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner. Seed funding will accelerate development of Shift Bioscience’s platform for identification of safe rejuvenation genes, a fundamental step forward in the development of therapeutics to treat age-related diseasesReadmore

    03 OCT
    2024

    UR Scientists Working to Crack Enduring Mystery of Bone Loss, Regeneration

    UR Scientists Working to Crack Enduring Mystery of Bone Loss, RegenerationReadmore


    view all Updates
    08:00-09:00

    Registration

    09:00-09:30

    Opening Ceremony and Introduction

    09:30-10:10

    Keynote Session I

    10:10-10:50

    Keynote Session II

    10:50-11:00

    Refreshment Break

    11:00-15:00

    Break Out Session I

    15:00-15:10

    Refreshment Break

    15:10-18:00

    Break Out Session II

    09:30-10:10

    Keynote Session III

    10:10-10:50

    Keynote Session IV

    10:50-11:00

    Refreshment Break

    11:00-15:00

    Break Out Session III

    15:00-15:10

    Refreshment Break

    15:10-18:00

    Break Out Session IV

    Get more information

    make a booking now

    Market Reports

    view all Reports

    Subscribe to our News & Updates